Paper of the Month - February, 2011

0 rating

Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study.

Coleman RE, Banks LM, Girgis SI et al.


READER POLL

Breast Cancer Poll 1
What approach do you currently use for the treatment of patients with HER2-overexpressing metastatic breast cancer whose disease has progressed despite trastuzumab?






Powered by NetPolls

WEB LINKS

SUBMIT AN ARTICLE